Announced
Completed
Financials
Tags
Pharmaceuticals
Acquisition
Single Bidder
Austria
probiotics
Majority
Private
Friendly
Cross Border
Completed
Synopsis
Chr. Hansen, a developer and producer of natural ingredients, completed the acquisition of HSO Health Care, an Austria-based B2B company specializing in probiotics. Financial terms were not disclosed. “I am excited that we have reached an agreement with HSO Health Care, which has demonstrated very fast growth through a globally recognized portfolio that complements our own UREX™ products nicely. Women’s health is a high-growth segment where innovation is becoming increasingly important, and with the addition of the Astarte™ portfolio we will be able to deliver innovation to a much larger market more quickly,” Mauricio Graber, Chr. Hansen CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.